28.03.2023,
1950 Zeichen
Amsterdam (ots/PRNewswire) - BeVinced, a new leading Clinical
Research Organization (CRO) specializing in Medical Device Regulation
(MDR) compliance services, is proud to announce the launch of its
services aimed at addressing the unique needs of the medical device
industry.
The company was started by two recognized experts in the MedTech CRO
arena: Joris Bannenberg and Dirk Meijer, both MD. They founded
Factory CRO in 1988 (now Avania) and each bring more than 30 years of
experience.
"We are thrilled to launch our niche CRO services for the MedTech
industry. BeVinced's team of experts in clinical research and
regulatory compliance is dedicated to supporting its clients in
navigating the complex regulatory landscape and bringing and keeping
their innovative medical devices to the EU market," said Dirk Meijer,
CEO of BeVinced.
The services include, but are not limited to, clinical trial design
and management, regulatory strategy and submissions, post-market
surveillance, vigilance, CER-writing and technical documentation
support as well as Legal Representative services.
"The MDR has a huge impact on the availability of certain medical
devices. Especially smaller companies and startups may not have
enough funding to outsource the MDR's Post Market Surveillance
programs. For this reason, some companies have even taken their
devices from the market. We see a real need for high-quality services
but at lower costs; BeVinced can do that with knowledge, supporting
digital technologies, well designed studies, and a nimble
organization." said Joris Bannenberg, CMO of BeVinced.
For more information about BeVinced and our niche CRO services for
the MedTech industry, please visit our website at www.bevinced.com.
Logo -
https://mma.prnewswire.com/media/2040194/3955265/Bevinced...
View original
content:https://www.prnewswire.co.uk/news-releases/bevinced-launches-
medtech-cro-services-301781351.html
Digital press kit:
http://www.ots.at/pressemappe/PR169392/aom
BSN Podcasts
Christian Drastil: Wiener Börse Plausch
Wiener Börse Plausch S4/78: Sads es olle deppat? Rechnen bei SPÖ und OMV, High Do&Co, Valneva Werner Lanthaler
Aktien auf dem Radar:Kapsch TrafficCom, Warimpex, Agrana, Austriacard Holdings AG, Pierer Mobility, FACC, ATX TR, Lenzing, voestalpine, Cleen Energy, Athos Immobilien, Österreichische Post, DO&CO, OMV, UBM, Amag, Flughafen Wien, Mayr-Melnhof, Strabag, Telekom Austria, Uniqa, VIG.
Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.
>> Besuchen Sie 66 weitere Partner auf boerse-social.com/partner
Mehr aktuelle OTS-Meldungen HIER